Intranasal insulin neuroprotection in ischemic stroke.

about

A population-based incidence of acute large vessel occlusions and thrombectomy eligible patients indicates significant potential for growth of endovascular stroke therapy in the USA.Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.

P2860

Q38378812-EE089A74-8CB0-40E3-89B1-06EED94354E0 Q47906548-782A103E-67D0-4E70-A27C-A088AF7B916D

P2860

Intranasal insulin neuroprotection in ischemic stroke.

Item

http://www.wikidata.org/entity/Q36790800

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intranasal insulin neuroprotection in ischemic stroke.

@ast

Intranasal insulin neuroprotection in ischemic stroke.

@en

type

Item

label

Intranasal insulin neuroprotection in ischemic stroke.

@ast

Intranasal insulin neuroprotection in ischemic stroke.

@en

prefLabel

Intranasal insulin neuroprotection in ischemic stroke.

@ast

Intranasal insulin neuroprotection in ischemic stroke.

@en

P1476

Intranasal insulin neuroprotection in ischemic stroke.

@en

P2093

Vasileios-Arsenios Lioutas

http://www.w3.org/2001/XMLSchema#string

Vera Novak

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin in central nervous system: more than just a peripheral hormone

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy.

Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.

Intranasal delivery of biologics to the central nervous system.

Randomized assessment of rapid endovascular treatment of ischemic stroke.

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.

A randomized trial of intraarterial treatment for acute ischemic stroke.

P304

400-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.179040

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27127468

http://www.w3.org/2001/XMLSchema#string

P932

4828994

http://www.w3.org/2001/XMLSchema#string

Intranasal insulin neuroprotection in ischemic stroke.

about

P2860

P2860

Intranasal insulin neuroprotection in ischemic stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932